Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

TGA Issues Guidance on Clinical Decision Support Software

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

Beginning Feb. 25, the way that software-based medical devices are regulated in Australia will change, and clinical decision support software (CDSS) that meets the definition of a medical device must…

Continue ReadingTGA Issues Guidance on Clinical Decision Support Software

New MDR Notified Body Designated in Finland

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

SGS FIMKO Oy, a Helsinki-based subsidiary of the certification giant SGS, became the 18th notified body to be designated to provide product certifications under the European Medical Device Regulation (MDR).…

Continue ReadingNew MDR Notified Body Designated in Finland

EC Details How Legacy Devices Will Be Managed in Eudamed

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

The European Commission released new guidance explaining how Legacy Devices will be identified in the Eudamed database and how their unique device identifiers will be generated and assigned. Source: The…

Continue ReadingEC Details How Legacy Devices Will Be Managed in Eudamed

FDA’s Device Center Has COVID Test Regrets

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

The FDA’s top device officials admit that allowing a flood of COVID-19 diagnostic tests onto the market last year that did not go through the usual clearance or approval steps…

Continue ReadingFDA’s Device Center Has COVID Test Regrets

FDA Appoints Kevin Fu As First Medical Device Cybersecurity Chief

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

The FDA has named Kevin Fu as acting director of medical device cybersecurity within the Center for Devices and Radiological Health (CDRH) — a newly created position in response to…

Continue ReadingFDA Appoints Kevin Fu As First Medical Device Cybersecurity Chief

New Postmarket Surveillance Tool for COVID-19 Vaccines

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

Health officials are using new tools to gather postmarket safety data on COVID-19 vaccines, including a new early warning system called V-Safe. Source: The GMP Letter

Continue ReadingNew Postmarket Surveillance Tool for COVID-19 Vaccines

EC Agrees on Common List of COVID-19 Rapid Antigen Tests

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

The European Commission (EC) has agreed on a common framework for the use and validation of rapid antigen tests and COVID-19 test results that EU member states will mutually recognize,…

Continue ReadingEC Agrees on Common List of COVID-19 Rapid Antigen Tests

New York Contract Manufacturer Hit for Repeat Observations

  • Post author:Sam
  • Post published:February 4, 2021
  • Post category:The GMP Letter

Failure to control product that did not conform to specifications, and failure to validate software landed contract manufacturer Viant AS&O Holdings in hot water with the FDA following an Oct.…

Continue ReadingNew York Contract Manufacturer Hit for Repeat Observations

FDA Issues Final Guidance on New Review Path for Safer Technologies

  • Post author:Sam
  • Post published:February 4, 2021
  • Post category:The GMP Letter

The FDA is introducing a new review program for medical devices and device-led combination products that are expected to significantly improve the safety of treatments for a disease or condition…

Continue ReadingFDA Issues Final Guidance on New Review Path for Safer Technologies

TGA Investigates COVID-19 Tests and Emerging Variants

  • Post author:Sam
  • Post published:February 4, 2021
  • Post category:The GMP Letter

Australia’s Therapeutic Goods Administration is conducting a postmarket review of all COVID-19 point-of-care and laboratory tests listed in the Australian Register of Therapeutic Goods to ensure that they can detect…

Continue ReadingTGA Investigates COVID-19 Tests and Emerging Variants
  • 1
  • 2
  • 3
  • 4
  • …
  • 44
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.